FAQS
- How often is this website updated?
This website is updated on daily following public announcements by the various regulatory agencies or companies involved in developing and/or marketing drugs for obesity and type 2 diabetes.
- Does this information cover only the US market or other markets as well?
Diabesity Digest makes an effort to include global information on its website. While information from both the US and the European regulatory agencies and companies is more readily available, we have also included information from other geographic areas and plan on expanding this content.
- Who is this website intended for?
This website is intended for use by business, financial, investment and medical professionals interested in learning about non-insulin prescriptions drugs available for obesity and type 2 diabetes.
- Who updates this website?
The contents of this website is updated by the staff at Diabesity Digest and is reviewed, as needed, by leading experts in the field of obesity and type 2 diabetes.
- Where does the information for this website come from?
Diabesity Digest uses various sources of information to update this website. These include mainly corporate press releases and regulatory filings from companies involved in marketing and developing the drugs/drug candidates listed on this website. In addition, Diabesity Digest may also on occasions contact the companies directly or any other pertinent sources to confirm the accuracy of information.
